NOT KNOWN DETAILS ABOUT AGO TUMOR

The changes in the 2011 version when compared to the previous version mirror the statements outlined previously mentioned. It may be downloaded atThe recommendation is in part according to new proof resulting from a systematic critique of your Cochrane Collaboration [102]. Examining the information of RCTs addressing hypofractionated RT, the author